Skip to content
value.today

Topica Pharmaceuticals Inc

🇺🇸 Palo Alto, California, USAPharmaceuticalsFounded 2010
Total raised
$32 M
1 round on record
Latest round
$32 M
Oct 2011
First round on record
Oct 2011
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Topica Pharmaceuticals Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2011$32 MNo. 1$10 to $50 million

Topica Pharmaceuticals Inc: Raise no. 1, Oct 2011

Investors in this round

11 investors had bought by the notice of Jun 10, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $36 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sales and issuance of Series B Preferred Stock and the underlying Common Stock issuable upon conversion thereof
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Gregory Vontz · Executive Officer, Director
  • Joseph Kirk Golemme · Executive Officer
  • Charles Gregory Homcy, MD · Director
  • David Kirk Cohen, MD · Director
  • G. Kirk Raab · Director
  • Russell Gregory Hirsch, MD, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Joseph Golemme, Chief Financial Officer. Newest notice filed Jun 10, 2013 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Topica Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Jun 2013).

    SEC Form D · Jun 2013

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jun 2013

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Topica Pharmaceuticals Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Topica Pharmaceuticals Inc
NameRoleNamed in
Charles Gregory VontzExecutive officerJun 2013
Joseph Kirk GolemmeExecutive officerJun 2013
Catherine E. De Porceri-MortonExecutive officerOct 2011
Joseph E. GolemmeExecutive officerOct 2011
Norifumi E. NakamuraExecutive officerOct 2011
Charles Gregory Homcy, MDDirectorJun 2013
Charles Gregory VontzDirectorJun 2013
David Kirk Cohen, MDDirectorJun 2013
G. Kirk RaabDirectorJun 2013
Russell Gregory Hirsch, MD, Ph.D.DirectorJun 2013
Alex Gregory BarkasDirectorOct 2011
Charles Gregory Homcy MDDirectorOct 2011
David E. Cohen MD MPHDirectorOct 2011